SCHEMBL7707708

SCHEMBL7707708

CCCc1[nH]c2cc(C(N)=O)cc(Cc3ccccc3C(=O)OC)c2c1C(=O)C(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ALDH1A1 P00352 2/20 0.37
LMNA P02545 2/20 0.37
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
NFKB1 P19838 1/20 0.35
CYP2C19 P33261 1/20 0.35
BLM P54132 1/20 0.35
PMP22 Q01453 1/20 0.35
HIF1A Q16665 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PPARG P37231 6/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6930961 0.85 ALOX5 (0.39) KMT2AMEN1ATML3MBTL1ALDH1A1
SCHEMBL7710517 0.77 PPARG (0.38) KMT2AMEN1ATML3MBTL1PPARG
SCHEMBL7707705 0.76 SMN1; SMN2 (0.42) KMT2AMEN1ATML3MBTL1ALDH1A1
SCHEMBL8556176 0.74 MEN1 (0.42) KMT2AMEN1ATML3MBTL1ALDH1A1
SCHEMBL8554263 0.74 ALOX5 (0.39) KMT2AMEN1ATML3MBTL1ALDH1A1
SCHEMBL8558633 0.73 ALOX5 (0.40) ALDH1A1LMNAMAPTPDE3BPDE3A
SCHEMBL8551585 0.73 SMN1; SMN2 (0.48) KMT2AMEN1ATML3MBTL1ALDH1A1
Hydrochloric Acid SCHEMBL8627726 0.73 ALOX5 (0.40) ALDH1A1LMNAMAPTPDE3BPDE3A
SCHEMBL7422800 0.72 KMT2A (0.58) KMT2AMEN1ATML3MBTL1ALDH1A1
SCHEMBL8555588 0.72 SMN1; SMN2 (0.47) KMT2AMEN1ATML3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed